PharmaLundensis AB announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was SEK 622,093 compared to SEK 943,398 a year ago. Net loss was SEK 722,985 compared to SEK 1.015 million a year ago. For the half year, operating loss was SEK 1.202 million compared to SEK 1.673 million a year ago. Net loss was SEK 1.397 million compared to SEK 1.810 million a year ago.